Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).
Financial Results:
Ajanta Pharma Ltd reported Revenues for Q2FY25 of ₹1,187.00 Crores up from ₹1,028.00 Crore year on year, a rise of 15.47%.
Total Expenses for Q2FY25 of ₹915.00 Crores up from ₹774.00 Crores year on year, a rise of 18.22%.
Consolidated Net Profit of ₹216.00 Crores up 10.77% from ₹195.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹17.33, up 11.73% from ₹15.51 in the same quarter of the previous year.